In Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Carbapenem-resistant Enterobacterales (CRE) Collected in Africa/Middle East ATLAS Global Surveillance Program 2018-2022

Introduction: Avibactam (AVI) is a non-β-lactam β-lactamase inhibitor that when combined with the β-lactam ceftazidime (CAZ) has demonstrated activity against Class A, Class C and some Class D enzymes. This study evaluated the in vitro activity of ceftazidime-avibactam against carbapenem-resistant E...

Full description

Saved in:
Bibliographic Details
Main Authors: Dr Meredith Hackel, Dr Gregory Stone, Dr Daniel Sahm
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224007069
Tags: Add Tag
No Tags, Be the first to tag this record!